You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Development of novel flexible lipid-vesicles of an estrogen receptor modulator
- In: J8 - Competition - Short Oral Communications of the FIP Industrial Pharmacy Section on Tuesday, 6 September 2011, 14:15-16:45
- At: Hyderabad (India) (2011)
- Type: Presentations + Posters
- By: DHONE, Deepa (UIPS, Panjab University, Chandigarh, India)
- Co-author(s): Bhatia, Amit (UIPS, Panjab University, Chandigarh, India)
Raza, Kaisar (UIPS, Panjab University, Chandigarh, India)
Singh, Bhupinder (UIPS, Panjab University, Chandigarh, India)
Katare, Om Prakash (UIPS, Panjab University, Chandigarh, India) - Abstract:
Tamoxifen (TAM) is a non-steroidal estrogen receptor modulator indicated in the management of breast cancer. The key objectives of the study include development, optimization, characterization and evaluation of flexible lipid-vesicles (FLVs) of TAM for in-vitro cytotoxicity and pharmacodynamic activity using suitable animal models. TAM-loaded FLVs
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026